Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. E.G.E. (Elisabeth) de Vries

Publicaties

Author Correction: Whole-body CD8 + T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.

Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer

From Algorithms to Meaningful Biomarkers: Anchoring AI in Clinical Oncology

Automated Whole-Body PET/CT Lesion Tracking for Lesion-Wise Response Evaluation in Metastatic Breast Cancer

Comparative analysis of FES-PET/CT and FDG-PET/CT in patients with ER-positive metastatic invasive lobular breast cancer

COVID-19 Vaccine Effectiveness in Patients with Hematologic Malignancies: a Nationwide Cohort Study

Demystifying the WHO Model Lists of Essential Medicines for cancer care

Dose optimisation to improve access to effective cancer medicines

ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)

Pers/media

Voor toekomstbestendige geneesmiddelenzorg is de wetenschap onmisbaar

FORESIGHT doet onderzoek naar juiste patiënt en passende therapie

Major funding boost for molecular imaging in drug development

New consortium for immunotherapy research

FORESIGHT consortium encourages molecular imaging in developing new drugs

FORESIGHT consortium secures €9 million to fast-track drug development

Inschrijving 30e Oncologiedagen geopend

Van Laarhoven nieuw lid raad van toezicht IKNL